查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629319

吸入膠囊市場，按配方、應用、釋放機制、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Inhalation Capsules Market, By Formulation, By Application, By Release Mechanism, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年吸入膠囊市場規模為8.319億美元，2024年至2032年複合年成長率為6.50%。

吸入膠囊市場-市場動態

呼吸道疾病盛行率上升推動市場需求

呼吸系統疾病盛行率的上升是推動醫藥市場對吸入膠囊需求的重要因素。由於空氣污染、吸菸、人口老化和遺傳傾向等因素，氣喘、慢性阻塞性肺病 (COPD) 和其他肺部相關疾病等呼吸系統疾病變得更加常見。這些病症通常需要長期管理，吸入療法被認為是最有效的治療選擇之一，可以提供快速且有針對性的緩解。

隨著呼吸系統疾病數量的增加，對更有效、更方便的治療方法的需求也隨之增加。吸入膠囊可提供精確的劑量並有效地將藥物直接輸送至肺部，正在成為哮喘和慢性阻塞性肺病等患者的首選。這些膠囊可以更好地在肺部吸收藥物，改善治療效果並減少口服治療中出現的全身性副作用的頻率。突顯這一趨勢的一項統計數據是，據世界衛生組織(WHO) 稱，預計到2030 年，慢性阻塞性肺病將成為全球第三大死亡原因。病率的不斷上升，刺激了對慢性阻塞性肺病的需求。因此，隨著製藥公司不斷開發創新解決方案來解決這些廣泛存在的呼吸系統疾病，吸入膠囊市場預計將顯著成長。

吸入膠囊市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.50% 左右的複合年成長率成長
  • 根據配方細分，預計粉吸入膠囊將在 2023 年佔據最大市場佔有率
  • 根據應用細分，氣喘是 2023 年的領先細分市場
  • 按地區分類，北美是 2023 年的主要收入來源

吸入膠囊市場-細分分析：

全球吸入膠囊市場根據配方、應用、釋放機制和地區進行細分。

市場依劑型分為三類：粉末吸入膠囊和液體填充膠囊。粉末吸入膠囊領域在市場上佔據主導地位。由於幾個關鍵因素，粉末吸入膠囊行業在市場上佔據主導地位。首先，它們將有效的藥物直接輸送到肺部，這是氣喘和慢性阻塞性肺病等疾病最需要的地方。細粉末確保深入肺部滲透，最大限度地發揮藥物的功效。

根據應用，市場分為兩類：氣喘、慢性阻塞性肺病、肺部感染和肺動脈高壓。氣喘在市場上佔據主導地位，並且由於其高盛行率、環境觸發因素和持續的治療進展，在預測期內可能會保持其主導地位。全球有超過 2.6 億人患有氣喘，使其成為最常見的慢性呼吸道疾病之一。龐大的患者群體推動了對氣喘治療（包括吸入療法）的持續需求

吸入膠囊市場 - 地理洞察

由於呼吸系統疾病的盛行率不斷上升以及先進給藥系統的日益採用，吸入膠囊市場在各個地區都在成長。由於完善的醫療基礎設施、高額醫療支出以及大量患有氣喘和慢性阻塞性肺病等呼吸系統疾病的患者群體，北美佔據了相當大的佔有率。歐洲也發揮關鍵作用，人口老化不斷加劇，強大的醫療保健系統支持吸入療法的採用。在亞太地區，由於呼吸道疾病發病率上升、醫療基礎設施不斷擴大以及政府旨在改善醫療保健可近性的舉措，預計市場將快速成長。由於吸煙率上升、城市化和空氣污染，拉丁美洲的需求不斷增加，而中東和非洲面臨日益嚴重的呼吸道疾病負擔，但獲得先進醫療保健的機會卻更加有限。然而，這些地區持續的醫療保健改善預計將推動未來市場的成長。

吸入膠囊市場-競爭格局：

由於對有效呼吸治療的需求不斷成長以及藥物輸送技術的不斷進步，吸入膠囊市場競爭激烈。公司正在專注於開發創新的吸入產品，特別是乾粉吸入器（DPI），其改進的配方可提供更好的生物利用度和更快的起效。製藥公司、研究機構和醫療保健提供者之間的策略夥伴關係和合作對於擴大市場覆蓋範圍和增強產品供應至關重要。此外，確保監管合規性並獲得不同地區衛生當局的批准對於市場參與者保持競爭力和維持產品可用性至關重要，從而進一步推動市場的成長。

最新進展：

  • 2024 年 2 月，康泰倫特宣佈在其馬薩諸塞州波士頓工廠增加了吸入乾粉的強效膠囊填充能力。此次擴張旨在滿足製藥業對複雜藥物輸送解決方案不斷成長的需求。新功能將支援客戶開發吸入療法，增強康泰倫特在生物製劑和先進藥物製劑領域的產品。
  • 2023 年8 月，Lupin 在美國推出了用於治療慢性阻塞性肺病的噻托銨乾粉吸入器，透過具有成本效益的解決方案擴大了其呼吸產品組合，旨在改善患者獲得這一關鍵治療的機會。
  • 2024 年 6 月，Verona Pharma 宣布美國 FDA 批准 Ohtuvayre(TM)（ensifentrine），一種治療慢性阻塞性肺病（COPD）的新型療法，標誌著該公司呼吸治療產品線的一個重要里程碑。該批准預計將透過在單一吸入療法中結合支氣管擴張劑和抗發炎特性來加強對慢性阻塞性肺病症狀的管理，為目前治療無法充分控制的患者提供新的選擇。

目錄

第 1 章：吸入膠囊市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按配方分類的吸入膠囊市場片段
    • 吸入膠囊市場片段（依應用）
    • 吸入膠囊市場片段（依釋放機制）
    • 按國家/地區分類的吸入膠囊市場片段
    • 按地區分類的吸入膠囊市場片段
  • 競爭洞察

第 3 章：吸入膠囊主要市場趨勢

  • 吸入膠囊市場促進因素
    • 市場促進因素的影響分析
  • 吸入膠囊市場限制
    • 市場限制影響分析
  • 吸入膠囊市場機會
  • 吸入膠囊市場未來趨勢

第 4 章：吸入膠囊產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：吸入膠囊市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：吸入膠囊市場格局

  • 2023 年吸入膠囊市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：吸入膠囊市場 - 按配方

  • 概述
    • 按配方分類的細分市場佔有率分析
    • 粉狀吸入膠囊
    • 液體填充膠囊

第 8 章：吸入膠囊市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 氣喘
    • 慢性阻塞性肺臟疾病
    • 肺部感染
    • 肺循環血壓過高

第 9 章：吸入膠囊市場 - 按釋放機制

  • 概述
    • 按發行機制分類的細分市佔率分析
    • 立即發布
    • 受控釋放

第 10 章：吸入膠囊市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美吸入膠囊主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按配方）
    • 北美市場規模和預測（按應用）
    • 北美市場規模與預測（按發布機制）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲吸入膠囊主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按配方）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按發布機制）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區吸入膠囊主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 按配方分類的亞太市場規模和預測
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（按發布機制）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲吸入膠囊主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按形式）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按發布機制）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲吸入膠囊主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按配方）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按發布機制）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 吸入膠囊產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Novartis International AG
    • Cipla Limited
    • Boehringer Ingelheim GmbH
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Lupin Pharmaceuticals, Inc.
    • UCB SA
    • Hovione
    • Dr. Reddy's Laboratories Ltd.
    • Laboratorios Farmaceuticos Rovi, SA
    • Vectura Group plc
    • MannKind Corporation
    • Catalent Pharma Solutions
    • Pfizer Inc.
    • Ferring Pharmaceuticals Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4501

REPORT HIGHLIGHT

Inhalation Capsules Market size was valued at USD 831.90 Million in 2023, expanding at a CAGR of 6.50% from 2024 to 2032.

Inhalation capsules are specialized pharmaceutical capsules containing powdered medication intended for delivery directly into the lungs through inhalation. These capsules are used with inhalation devices and are designed to ensure the medication reaches the lungs efficiently. This method of drug delivery is particularly important for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where localized treatment is crucial. The inhalation route allows for faster onset of action compared to oral medications, as it bypasses the digestive system, providing quicker relief. Additionally, it reduces the risk of systemic side effects since the drug is targeted directly to the lungs, improving the overall effectiveness and safety of treatment.

Inhalation Capsules Market- Market Dynamics

Rising prevalence of respiratory diseases to propel market demand

The rising prevalence of respiratory diseases is a significant factor driving the demand for inhalation capsules in the pharmaceutical market. Respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions, have become more common due to factors like air pollution, smoking, aging populations, and genetic predispositions. These conditions often require long-term management, and inhalation therapies are considered one of the most effective treatment options, offering rapid and targeted relief.

As respiratory diseases grow in number, the need for more effective and convenient treatments also rises. Inhalation capsules, which provide a precise dosage and efficient drug delivery directly to the lungs, are becoming a preferred choice for patients with conditions like asthma and COPD. These capsules allow for better drug absorption in the lungs, improving therapeutic outcomes and reducing the frequency of systemic side effects seen with oral treatments. One statistic that highlights this trend is that, according to the World Health Organization (WHO), COPD is expected to become the third leading cause of death worldwide by 2030. This increase in COPD cases, alongside the growing asthma prevalence, fuels the demand for effective inhalation therapies. As a result, the inhalation capsule market is projected to experience significant growth as pharmaceutical companies continue to develop innovative solutions to address these widespread respiratory conditions.

Inhalation Capsules Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.50% over the forecast period (2024-2032)
  • Based on formulation segmentation, Powdered Inhalation Capsules was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Asthma was the leading segment in 2023
  • On the basis of region, North America was the leading revenue generator in 2023

Inhalation Capsules Market- Segmentation Analysis:

The Global Inhalation Capsules Market is segmented on the basis of Formulation, Application, Release Mechanism and Region.

The market is divided into three categories based on formulation: powdered inhalation capsules, and liquid-filled capsules. The powdered inhalation capsules sector dominates the market. The powdered inhalation capsules sector dominates the market due to several key factors. First, they provide efficient drug delivery directly to the lungs, where they are most needed for conditions like asthma and COPD. The fine powder ensures deep lung penetration, maximizing the drug's effectiveness.

The market is divided into two categories based on application: asthma, chronic obstructive pulmonary disease, pulmonary infections, and pulmonary hypertension. Asthma dominates the market and is likely to maintain its dominance during the forecast period due to its high prevalence, environmental triggers, and ongoing treatment advancements. Over 260 million people worldwide suffer from asthma, making it one of the most common chronic respiratory diseases. This large patient population drives continuous demand for asthma treatments, including inhalation therapies

Inhalation Capsules Market- Geographical Insights

The inhalation capsules market is experiencing growth across various regions due to the increasing prevalence of respiratory diseases and the rising adoption of advanced drug delivery systems. North America holds a significant share, driven by a well-established healthcare infrastructure, high healthcare spending, and a large patient population with respiratory conditions like asthma and COPD. Europe also plays a key role, with a growing aging population and strong healthcare systems supporting the adoption of inhalation therapies. In Asia-Pacific, rapid market growth is expected, fueled by rising respiratory disease incidences, expanding healthcare infrastructure, and government initiatives aimed at improving healthcare access. Latin America is seeing increased demand due to rising smoking rates, urbanization, and air pollution, while the Middle East and Africa face a growing respiratory disease burden but have more limited access to advanced healthcare. However, ongoing healthcare improvements in these regions are expected to drive future market growth.

Inhalation Capsules Market- Competitive Landscape:

The inhalation capsules market is highly competitive, driven by the increasing demand for effective respiratory treatments and continuous advancements in drug delivery technologies. Companies are focusing on developing innovative inhalation products, particularly dry powder inhalers (DPIs), with improved formulations that offer better bioavailability and faster onset of action. Strategic partnerships and collaborations between pharmaceutical companies, research organizations, and healthcare providers are crucial in expanding market reach and enhancing product offerings. Additionally, ensuring regulatory compliance and obtaining approvals from health authorities across different regions is vital for market players to stay competitive and maintain product availability, further fueling the growth of the market.

Recent Developments:

  • In February 2024, Catalent announced the addition of potent capsule filling capabilities for inhaled dry powders at its Boston, MA facility. This expansion aims to meet the growing demand for complex drug delivery solutions in the pharmaceutical industry. The new capabilities will support clients developing inhalation therapies, enhancing Catalent's offerings in the field of biologics and advanced drug formulations.
  • In August 2023, Lupin launched its Tiotropium Dry Powder Inhaler in the United States for the treatment of COPD, expanding its respiratory portfolio with a cost-effective solution aimed at improving patient access to this critical therapy.
  • In June 2024, Verona Pharma announced the U.S. FDA approval of Ohtuvayre(TM) (ensifentrine), a novel treatment for chronic obstructive pulmonary disease (COPD), marking a significant milestone in the company's respiratory therapeutics pipeline. The approval is expected to enhance the management of COPD symptoms by combining both bronchodilator and anti-inflammatory properties in a single inhaled therapy, offering a new option for patients who are not adequately controlled with current treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INHALATION CAPSULES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis International AG
  • Cipla Limited
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • UCB S.A.
  • Hovione
  • Dr. Reddy's Laboratories Ltd.
  • Laboratorios Farmaceuticos Rovi, S.A.
  • Vectura Group plc
  • MannKind Corporation
  • Catalent Pharma Solutions
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Others

GLOBAL INHALATION CAPSULES MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Powdered Inhalation Capsules
  • Liquid-filled Capsules

GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Infections
  • Pulmonary Hypertension

GLOBAL INHALATION CAPSULES MARKET, BY RELEASE MECHANISM- MARKET ANALYSIS, 2019 - 2032

  • Immediate Release
  • Controlled Release

GLOBAL INHALATION CAPSULES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Inhalation Capsules Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Inhalation Capsules Market Snippet by Formulation
    • 2.1.2. Inhalation Capsules Market Snippet by Application
    • 2.1.3. Inhalation Capsules Market Snippet by Release Mechanism
    • 2.1.4. Inhalation Capsules Market Snippet by Country
    • 2.1.5. Inhalation Capsules Market Snippet by Region
  • 2.2. Competitive Insights

3. Inhalation Capsules Key Market Trends

  • 3.1. Inhalation Capsules Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Inhalation Capsules Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Inhalation Capsules Market Opportunities
  • 3.4. Inhalation Capsules Market Future Trends

4. Inhalation Capsules Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Inhalation Capsules Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Inhalation Capsules Market Landscape

  • 6.1. Inhalation Capsules Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Inhalation Capsules Market - By Formulation

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Formulation, 2023 & 2032 (%)
    • 7.1.2. Powdered Inhalation Capsules
    • 7.1.3. Liquid-filled Capsules

8. Inhalation Capsules Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Asthma
    • 8.1.3. Chronic Obstructive Pulmonary Disease
    • 8.1.4. Pulmonary Infections
    • 8.1.5. Pulmonary Hypertension

9. Inhalation Capsules Market - By Release Mechanism

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Release Mechanism, 2023 & 2032 (%)
    • 9.1.2. Immediate Release
    • 9.1.3. Controlled Release

10. Inhalation Capsules Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Inhalation Capsules Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Inhalation Capsules Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Inhalation Capsules Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Inhalation Capsules Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Inhalation Capsules Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Inhalation Capsules Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca PLC
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis International AG
    • 11.2.4. Cipla Limited
    • 11.2.5. Boehringer Ingelheim GmbH
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Sun Pharmaceutical Industries Ltd.
    • 11.2.8. Teva Pharmaceutical Industries Ltd.
    • 11.2.9. Lupin Pharmaceuticals, Inc.
    • 11.2.10. UCB S.A.
    • 11.2.11. Hovione
    • 11.2.12. Dr. Reddy's Laboratories Ltd.
    • 11.2.13. Laboratorios Farmaceuticos Rovi, S.A.
    • 11.2.14. Vectura Group plc
    • 11.2.15. MannKind Corporation
    • 11.2.16. Catalent Pharma Solutions
    • 11.2.17. Pfizer Inc.
    • 11.2.18. Ferring Pharmaceuticals Inc.
    • 11.2.19. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us